Published in
Elsevier, European Journal of Cancer, (79), p. 166-175, 2017
DOI: 10.1016/j.ejca.2017.03.004
Links
Tools
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)
Journal article published in 2017 by
Pierre Kerbrat,
Isabelle Desmoulins,
Lise Roca,
Christelle Levy,
Alain Lortholary,
Alain Marre,
Rémy Delva,
Maria Rios,
Patrice Viens,
Étienne Brain 
,
Daniel Serin,
Magali Edel,
Marc Debled,
Mario Campone,
Marie-Ange Mourret-Reynier
and other authors.
,
Daniel Serin,
Magali Edel,
Marc Debled,
Mario Campone,
Marie-Ange Mourret-Reynier
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 